1. Home
  2. CDT vs HLSQ Comparison

CDT vs HLSQ Comparison

Compare CDT & HLSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Conduit Pharmaceuticals Inc.

CDT

Conduit Pharmaceuticals Inc.

HOLD

Current Price

$0.25

Market Cap

1.1M

Sector

Health Care

ML Signal

HOLD

Logo Tessera Defense and Homeland Security Inc. Common Stock

HLSQ

Tessera Defense and Homeland Security Inc. Common Stock

N/A

Current Price

$0.26

Market Cap

972.0K

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CDT
HLSQ
Founded
2019
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1M
972.0K
IPO Year
2022
2018

Fundamental Metrics

Financial Performance
Metric
CDT
HLSQ
Price
$0.25
$0.26
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 1.4M
1.0M
Earning Date
11-12-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 560.42
EPS
N/A
★ 3.56
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$0.07
Revenue Growth
N/A
N/A
52 Week Low
$0.07
$0.23
52 Week High
$112,500.00
$0.77

Technical Indicators

Market Signals
Indicator
CDT
HLSQ
Relative Strength Index (RSI) 21.37 10.61
Support Level $0.07 N/A
Resistance Level $170.00 $0.45
Average True Range (ATR) 0.11 0.06
MACD 4.74 -0.01
Stochastic Oscillator 10.00 8.09

Price Performance

Historical Comparison
CDT
HLSQ

About CDT Conduit Pharmaceuticals Inc.

CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. It has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The company's pipeline includes candidates that target autoimmune disorders, as well as idiopathic male infertility, oncology, dermatology, rare disease and animal health. It has one operating segment focused on the research and development of clinical assets.

About HLSQ Tessera Defense and Homeland Security Inc. Common Stock

Tessera Defense and Homeland Security Inc develops and acquires technologies that identify, track, and counter physical threats across defense, security, critical infrastructure, and first-response markets - building a portfolio around the growing need for earlier, more accurate threat detection as UAVs and other autonomous systems reshape the operating environment. The Company's portfolio includes Zorronet, an AI-powered autonomous command-and-control platform, and DFSL, a developer of LADAR-based counter-UAS and perimeter security systems.

Share on Social Networks: